Congress trades
Arcutis Biotherapeutics, Inc. (ARQT)
About Arcutis Biotherapeutics, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Todd Franklin Watanabe
- Employees
- 354
- Listed since
- Jan 31, 2020
- Market value
- $3.0B
- Price to earnings
- 108.0
- Earnings per share
- $0.22
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 27, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $0.11 | $0.06 | $129.9M | $118.9M | EPS beatRevenue beat |
| Q1 FY2026reported May 6, 2026 | -$0.09 | -$0.02 | $105.4M | $103.7M | EPS missRevenue beat |
| Q4 FY2025reported Feb 25, 2026 | $0.13 | $0.03 | $129.5M | $113.1M | EPS beatRevenue beat |
| Q3 FY2025reported Oct 28, 2025 | $0.06 | -$0.10 | $99.2M | $110.8M | EPS beatRevenue miss |
| Q2 FY2025reported Aug 6, 2025 | -$0.13 | -$0.18 | $81.5M | $80.6M | EPS beatRevenue in line |
| Q1 FY2025reported May 6, 2025 | -$0.20 | -$0.21 | $65.8M | $72.7M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 21, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Todd Franklin WatanabePresident and Chief Executive Officer | $713K | $2.1M | $4.4M | $7.2M |
| L. Todd EdwardsChief Commercial Officer | $535K | $753K | $1.7M | $3.0M |
| Patrick E. BurnettM.D., Ph.D. Chief Medical Officer | $535K | $753K | $1.7M | $3.0M |
| Masaru Matsuda, J.D.Chief Legal Officer | $495K | $465K | $1.2M | $2.1M |
| Latha Vairavan | $419K | $440K | $1.1M | $1.9M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | $326.1M | 12,437,000 | +0.9% | 9.53% |
| Blackrock, Inc. | $276.5M | 10,545,466 | +14.6% | 8.08% |
| Frazier Life Sciences Management, L.P. | $258.9M | 9,874,511 | 0.0% | 7.57% |
| Rubric Capital Management LP | $216.9M | 8,271,577 | 0.0% | 6.34% |
| Polar Capital Holdings PLC | $173.2M | 6,606,945 | +16.6% | 5.06% |
| State Street Corp | $152.7M | 5,822,840 | -7.5% | 4.46% |
| Vanguard Capital Management LLC | $130.8M | 4,988,756 | +2.4% | 3.82% |
| Morgan Stanley | $116.7M | 4,451,014 | +5.5% | 3.41% |
| Jennison Associates LLC | $110.6M | 4,219,058 | -15.3% | 3.23% |
| D. E. Shaw & Co., Inc. | $103.6M | 3,949,609 | +58.2% | 3.03% |
| UBS Group AG | $87.4M | 3,333,015 | +0.1% | 2.55% |
| Bank Of America Corp | $78.3M | 2,987,431 | +34.5% | 2.29% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ARQT
6 disclosures of 6 on record · median 32d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +11.1%S&P +0.8% · vs S&P 500 +10.3% | May 29, 2026 | Jun 8, 2026 | 10d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +1.0%S&P +12.0% · vs S&P 500 -11.0% | Mar 3, 2026 | Apr 7, 2026 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -19.1%S&P +10.6% · vs S&P 500 -29.7% | Dec 11, 2025 | Jan 12, 2026 | 32d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +250.1%S&P +71.5% · vs S&P 500 +178.6% | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +70.5%S&P +84.3% · vs S&P 500 -13.8% | Apr 17, 2023 | May 19, 2023 | 32d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +16.0%S&P +101.1% · vs S&P 500 -85.1% | Jun 15, 2022 | Jul 22, 2022 | 37d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
2 members · estimate, as of Sep 10, 20262 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded ARQT?
Gilbert Ray Cisneros, Jr., Josh Gottheimer disclosed ARQT transactions in the filings shown here.
Which members of Congress hold ARQT?
2 members of Congress report a position in ARQT in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are ARQT trades disclosed?
Congressional disclosures took a median of 32 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.